The authors reply
Crit Care Med
.
2013 Dec;41(12):e488.
doi: 10.1097/CCM.0000000000000059.
Authors
Steven M Opal
1
,
R Phillip Dellinger
Affiliation
1
Infectious Disease Division, Memorial Hospital of Rhode Island, Providence, RI; Cooper Health Systems, Camden, NJ; for the Surviving Sepsis Campaign Guidelines Committee.
PMID:
24275421
DOI:
10.1097/CCM.0000000000000059
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / administration & dosage*
Critical Care*
Female
Heparin / administration & dosage*
Humans
Male
Venous Thromboembolism / prevention & control*
Substances
Anticoagulants
Heparin